Clinical Trial Update: Lovastatin for Treatment of Brain Arteriovenous Malformations [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating lovastatin for treatment of brain arteriovenous malformations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Arteriovenous Malformation

Drugs mentioned

• Lovastatin (Lovastatin)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Cerebral Arteriovenous Malformation | Phase 2 | Status: UNKNOWN